|Day Low/High||58.67 / 60.48|
|52 Wk Low/High||28.33 / 73.49|
But that's exactly where we are right now, in this third day of the rotation, so here's your path to safety.
I'm on the sidelines, but SNAP and DD are intriguing.
The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.
The Fed has done a lot, and is willing to do even more, but for now, is watching Congress. The fiscal side is where the next shoe falls.
A technical look at two chemical stocks: DuPont and Olin.
Other places besides the United States are flashing green, and they can surprise us -- even give our international companies a boost.
Don't just follow the herd, time your exits and entrances well -- even if it is a big player like Warren Buffett that is leading the charge.
Danielle DiMartino Booth asks whether a downturn in tech spending lies ahead: With major chemical companies such as DuPont and BASF pulling 2020 guidance, the Chemical Activity Barometer from the ACC provides a convenient macro proxy; this barometer...
For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.
These names are showing both technical and quantitative deterioration.
That's the question my wife asked me recently -- here's my answer.
It's no secret that the Fed would like to get out of the short-term repo business.
Chinese President Xi Jinping, not a man given to exaggerate, has referred to the spread of this coronavirus in China as 'a grave situation.'
I do think that this Fed Chair has learned to be cautious, in reflection of the policy errors made in late 2018.
* Only three of eleven S&P sectors are viewed as attractive * I am in a risk off state of mind. Back in 2015 I instituted a new regular feature called "Sectors," in which I periodically offered my short-term (6-12 months) price outlook for each of t...
The Fed chairman's news conference threw markets for a loop with hawkish words that did not support the Fed's dovish actions.
The problem is that the Fed's mission has moved beyond their mandate.
Recently spun off Dow Inc. sports an attractive dividend yield and valuation.
The endless rally needs fuel, and without it, you end up with what you got Tuesday, a soggy session that was hit from the cloud, Beyond Meat's chill, and big merger uncertainties.
Mr. Market re-embraces the cyclicals today ( , , , etc.). This may support the notion that I am on the right track with my bond short.
I have received a number of questions about weightings and trading around positions. I recently posted this explanation in our Comments Section: In recognition that there is more uncertainty about market outcomes and that there are agents such as ET...
Bayer's takeover of Monsanto is expected to receive extra scrutiny out of fears the deal could prove detrimental for European farmers.
There are two separate and positive developments at Allergan over the last three days that should continue to buoy its shares, which were up $6 on Friday. First, as I posted over the weekend: Allergan and the Tribe Have Spoken Sep 9, 2017 ' 9:29 AM...
My investing methodology is anticipatory rather than reactionary because I base trades on my fair market value calculations instead of price trends.